journal article·2021-09Open access

Chemical Stability of Metal‐organic Frameworks for Applications in Drug Delivery

Hana Bunzen

ChemNanoMat· Volume 7· Issue 9

Abstract

Abstract Structural variety, tunable porosity and opportunities for functionalization make metal‐organic frameworks (MOFs) promising materials for applications in medicine as drug delivery systems. In this minireview, an overview of chemical stability of MOF nanocarriers at simulated body conditions is presented. Parameters such as a choice of buffer, pH value, nanoparticle size or surface modification are discussed, as well as analytical methods and approaches suitable to determine the material stability. Last but not least, examples of tuning and improving the chemical stability of MOF nanoparticles for solution‐based drug delivery (oral and intravenous) are presented and examples of MOFs as pH‐responsive drug nanocarriers are given.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Metal-Organic Frameworks: Synthesis and Applications · Nanoparticle-Based Drug Delivery · Dendrimers and Hyperbranched Polymers

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Chair of Solid State and Materials Chemistry, Institute of Physics University of Augsburg Universitaetsstrasse 1 86159 Augsburg Germany

References (63)

Show source-provided references
1. 10.1002/adhm.20180100210.1002/adhm.201801002 ↗
2. 10.1038/s41573-020-0090-810.1038/s41573-020-0090-8 ↗
3. 10.1002/wnan.132510.1002/wnan.1325 ↗
4. 10.2147/IJN.S59610.2147/IJN.S596 ↗
5. 10.1002/biot.20200000510.1002/biot.202000005 ↗
6. 10.1002/smll.20190684610.1002/smll.201906846 ↗
7. 10.1039/C7TB02970E10.1039/C7TB02970E ↗
8. 10.1002/advs.20180152610.1002/advs.201801526 ↗
9. 10.1002/adma.20160613410.1002/adma.201606134 ↗
10. 10.1021/cr200256v10.1021/cr200256v ↗
11. 10.1098/rsta.2016.003210.1098/rsta.2016.0032 ↗
12. 10.1002/anie.20030063610.1002/anie.200300636 ↗
13. 10.1002/adma.20170430310.1002/adma.201704303 ↗
14. 10.1016/j.mattod.2017.07.00610.1016/j.mattod.2017.07.006 ↗
15. 10.1002/er.325510.1002/er.3255 ↗
16. 10.1002/chem.20180414910.1002/chem.201804149 ↗
17. 10.1039/C6CS00250A10.1039/C6CS00250A ↗
18. 10.1039/C9CS00778D10.1039/C9CS00778D ↗
19. 10.1021/cr200324t10.1021/cr200324t ↗
20. 10.1021/acs.chemrev.9b0076610.1021/acs.chemrev.9b00766 ↗
21. 10.1039/C8TA04220A10.1039/C8TA04220A ↗
22. 10.1039/C9SC03916C10.1039/C9SC03916C ↗
23. 10.1039/C9EN01321K10.1039/C9EN01321K ↗
24. 10.1021/acs.chemrev.9b0074610.1021/acs.chemrev.9b00746 ↗
25. 10.1039/C4CS00081A10.1039/C4CS00081A ↗
26. 10.1021/ja00905a00110.1021/ja00905a001 ↗
27. 10.1016/j.micromeso.2014.09.03410.1016/j.micromeso.2014.09.034 ↗
28. 10.1016/j.micromeso.2015.11.05510.1016/j.micromeso.2015.11.055 ↗
29. 10.1039/C9CE00757A10.1039/C9CE00757A ↗
30. 10.1080/10610278.2019.161608910.1080/10610278.2019.1616089 ↗
31. 10.1016/j.chempr.2017.02.00510.1016/j.chempr.2017.02.005 ↗
32. 10.1039/D0QI00973C10.1039/D0QI00973C ↗
33. 10.1021/la501255510.1021/la5012555 ↗
34. 10.1038/srep4309910.1038/srep43099 ↗
35. 10.14227/DT180311P1510.14227/DT180311P15 ↗
36. 10.14227/DT240317P3810.14227/DT240317P38 ↗
37. 10.1039/C6TB02025A10.1039/C6TB02025A ↗
38. 10.1002/advs.20180152610.1002/advs.201801526 ↗
39. 10.1016/j.micromeso.2017.04.04210.1016/j.micromeso.2017.04.042 ↗
40. 10.1016/j.ccr.2020.21365110.1016/j.ccr.2020.213651 ↗
41. 10.1016/j.addr.2010.04.00910.1016/j.addr.2010.04.009 ↗
42. Tannock I. F. · Cancer Res. · 1989 · 49 · 4373
43. Feng S. · Front. Chem. · 2021 · 15 · 221
44. 10.1039/D0RA07950B10.1039/D0RA07950B ↗
45. 10.1021/jacs.5b1172010.1021/jacs.5b11720 ↗
46. 10.1039/C3CC47666A10.1039/C3CC47666A ↗
47. 10.1021/nn406590q10.1021/nn406590q ↗
48. 10.1039/c2dt30357d10.1039/c2dt30357d ↗
49. 10.1002/chem.20190259910.1002/chem.201902599 ↗
50. 10.1002/ppsc.20200018510.1002/ppsc.202000185 ↗
51. 10.1002/cnma.20200022110.1002/cnma.202000221 ↗
52. 10.1039/C8TB01899E10.1039/C8TB01899E ↗
53. 10.1021/acsami.6b1137810.1021/acsami.6b11378 ↗
54. 10.1039/c3tb00026e10.1039/c3tb00026e ↗
55. 10.1039/C4CC02570A10.1039/C4CC02570A ↗
56. 10.1021/acs.molpharmaceut.6b0037410.1021/acs.molpharmaceut.6b00374 ↗
57. 10.1016/j.jssc.2016.02.04010.1016/j.jssc.2016.02.040 ↗
58. 10.1021/jacs.8b0208910.1021/jacs.8b02089 ↗
59. 10.1039/c3ta10662d10.1039/c3ta10662d ↗
60. 10.1039/C9DT01710K10.1039/C9DT01710K ↗
61. 10.1039/C4CC04458D10.1039/C4CC04458D ↗
62. 10.1002/cmdc.20160037410.1002/cmdc.201600374 ↗
63. 10.1039/C5CC05237H10.1039/C5CC05237H ↗